<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">34941153</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1536-5964</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>100</Volume>
            <Issue>51</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
              <Day>23</Day>
            </PubDate>
          </JournalIssue>
          <Title>Medicine</Title>
          <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Transcutaneous electrical stimulation therapy and genetic analysis in Dercum's disease: A pilot study.</ArticleTitle>
        <Pagination>
          <StartPage>e28360</StartPage>
          <MedlinePgn>e28360</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e28360</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000028360</ELocationID>
        <Abstract>
          <AbstractText>Dercum's disease (DD), or adiposis dolorosa, is a rare condition of unknown etiology characterized by growth of painful subcutaneous adipose tissue. No specific treatment exists. Pain is often invalidating and resistant to analgesic drugs. We tested the efficacy of Frequency Rhythmic Electrical Modulation System (FREMS) therapy on pain relief. Subcutaneous biopsies were performed for genetic analysis.Nine DD patients were enrolled. Five cycles of FREMS at 3-month intervals during 1 year were administered. Visual analogue scale (VAS), Bartel Index Questionnaire and Short Form 36 questionnaire were used to measure pain and general health status at baseline, 6 and 12 months. Dual-energy X-ray absorptiometry (DEXA) quantified fat mass. Next-Generation Sequencing (NGS) was performed on adipose tissue biopsies and peripheral blood sample to search for somatic variants and specific protein pathway mutation.Seven patients were included in the final analysis. FREMS induced a reduction in VAS score (from 92 to 52.5, P = .0597) and a significant improvement in SF-36 domains (Physical functioning, Role limitation due to physical health, Body pain, Vitality, Social functioning, P &lt; .05). No modification in anthropometrics and DEXA values was observed. The analysis of the mitochondrial Displacement loop (D-loop) region confirmed the clonality of all lipomatous lesions. The presence of the mitochondrially encoded tRNA-Lysine (MT-TK) m.8344A&gt;G variant, occasionally identified in patients with multiple symmetric lipomatosis, was excluded in all subjects. On the other hand, we observed variants in genes belonging to signaling pathways involved in cell cycle and proliferation (Phosphoinositide 3-kinase/AKT/mTOR, MAPK/ERK, and Hippo).FREMS can be a useful tool to alleviate pain and improve overall quality of life in patients with DD. Genetic analysis highlighted the molecular heterogeneity of lipomas.</AbstractText>
          <CopyrightInformation>Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Caretto</LastName>
            <ForeName>Amelia</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Errichiello</LastName>
            <ForeName>Edoardo</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Medical Genetics, Department of Molecular Medicine, University of Pavia, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patricelli</LastName>
            <ForeName>Maria Grazia</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology and Citogenetics, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zuffardi</LastName>
            <ForeName>Orsetta</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Medical Genetics, Department of Molecular Medicine, University of Pavia, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cristel</LastName>
            <ForeName>Giulia</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ravelli</LastName>
            <ForeName>Silvia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sirtori</LastName>
            <ForeName>Marcella</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Bone Metabolic Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scavini</LastName>
            <ForeName>Marina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bosi</LastName>
            <ForeName>Emanuele</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0002-2371-2495</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Vita-Salute San Raffaele University, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martinenghi</LastName>
            <ForeName>Sabina</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Medicine (Baltimore)</MedlineTA>
        <NlmUniqueID>2985248R</NlmUniqueID>
        <ISSNLinking>0025-7974</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000274" MajorTopicYN="N">Adiposis Dolorosa</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008067" MajorTopicYN="N">Lipoma</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004561" MajorTopicYN="Y">Transcutaneous Electric Nerve Stimulation</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have no funding and conflicts of interests to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>14</Hour>
          <Minute>7</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34941153</ArticleId>
        <ArticleId IdType="pmc">PMC8702289</ArticleId>
        <ArticleId IdType="doi">10.1097/MD.0000000000028360</ArticleId>
        <ArticleId IdType="pii">00005792-202112230-00129</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hansson E, Svensson H, Brorson H. Review of Dercum's disease and proposal of diagnostic criteria, diagnostic methods, classification and management. Orphanet J Rare Dis
2012;7:23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3444313</ArticleId>
            <ArticleId IdType="pubmed">22546240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campen R, Mankin H, Louis DN, Hirano M, Maccollin M. Familial occurrence of adiposis dolorosa. J Am Acad Dermatol
2001;44:132–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11148491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyllerman M, Brandberg G, Wiklund LM, Månsson JE. Dysarthria, progressive parkinsonian features and symmetric necrosis of putamen in a family with painful lipomas (Dercum disease variant). Neuropediatrics
2002;33:69–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12075486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holme E, Larsson NG, Oldfors A, Tulinius M, Sahlin P, Stenman G. Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A--&gt;G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet
1993;52:551–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1682176</ArticleId>
            <ArticleId IdType="pubmed">8447321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gámez J, Playán A, Andreu AL, et al. . Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA. Neurology
1998;51:258–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9674814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansson E, Svensson H, Brorson H. Liposuction may reduce pain in Dercum's disease (adiposis dolorosa). Pain Med
2011;12:942–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21481169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansson E, Manjer J, Svensson H, Brorson H. Quality-of-life in patients with Dercum's disease – before and after liposuction. J Plast Surg Hand Surg
2012;46:252–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22909243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lange U, Oelzner P, Uhlemann C. Dercum's disease (Lipomatosis dolorosa): successful therapy with pregabalin and manual lymphatic drainage and a current overview. Rheumatol Int
2008;29:17–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18604537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singal A, Janiga JJ, Bossenbroek NM, Lim HW. Dercum's disease (adiposis dolorosa): a report of improvement with infliximab and methotrexate. J Eur Acad Dermatol Venereol
2007;21:717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17448013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonciarz Z, Mazur W, Hartleb J, et al. . Interferon alfa-2b induced long-term relief of pain in two patients with adiposis dolorosa and chronic hepatitis C. J Hepatol
1997;27:1141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9453446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reggiani M, Errani A, Staffa M, Schianchi S. Is EMLA effective in Dercum's disease?
Acta Derm Venereol
1996;76:170–1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8740288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petersen P, Kastrup J. Dercum's disease (adiposis dolorosa). Treatment of the severe pain with intravenous lidocaine. Pain
1987;28:77–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3822497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atkinson RL. Intravenous lidocaine for the treatment of intractable pain of adiposis dolorosa. Int J Obes
1982;6:351–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7129748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herbst KL, Rutledge T. Pilot study: rapidly cycling hypobaric pressure improves pain after 5 days in adiposis dolorosa. J Pain Res
2010;3:147–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3004643</ArticleId>
            <ArticleId IdType="pubmed">21197318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ibarra M, Eekema A, Ussery C, Neuhardt D, Garby K, Herbst KL. Subcutaneous adipose tissue therapy reduces fat by dual X-ray absorptiometry scan and improves tissue structure by ultrasound in women with lipoedema and Dercum disease. Clin Obes
2018;8:398–406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30248251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinenghi S, Caretto A, Losio C, Scavini M, Bosi E. Successful treatment of Dercum's disease by transcutaneous electrical stimulation: a case report. Medicine (Baltimore)
2015;94:e950.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4616524</ArticleId>
            <ArticleId IdType="pubmed">26091459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosi E, Conti M, Vermigli C, et al. . Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia
2005;48:817–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15834546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosi E, Bax G, Scionti L, et al. . FREMS European Trial Study Group. Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial. Diabetologia
2013;56:467–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3563945</ArticleId>
            <ArticleId IdType="pubmed">23238789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janković A, Binić I. Frequency rhythmic electrical modulation system in the treatment of chronic painful leg ulcers. Arch Dermatol Res
2008;300:377–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18629524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santamato A, Panza F, Fortunato F, et al. . Effectiveness of the frequency rhythmic electrical modulation system for the treatment of chronic and painful venous leg ulcers in older adults. Rejuvenation Res
2012;15:281–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22676330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gandolfi A, Pontara A, Di Terlizzi G, et al. . Improvement in clinical symptoms of scleredema diabeticorum by frequency-modulated electromagnetic neural stimulation: a case report. Diabetes Care
2014;37:e233–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25342834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farina S, Casarotto M, Benelle M, et al. . A randomized controlled study on the effect of two different treatments (FREMS AND TENS) in myofascial pain syndrome. Eura Medicophys
2004;40:293–301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16175154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geurts-Giele WR, Gathier GH, Atmodimedjo PN, Dubbink HJ, Dinjens WN. Mitochondrial D310 mutation as clonal marker for solid tumors. Virchows Arch
2015;467:595–602.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4656708</ArticleId>
            <ArticleId IdType="pubmed">26276353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Errichiello E, Venesio T. Mitochondrial DNA variants in colorectal carcinogenesis: drivers or passengers?
J Cancer Res Clin Oncol
2017;143:1905–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28393270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou XP, Waite KA, Pilarski R, et al. . Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet
2003;73:404–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1180378</ArticleId>
            <ArticleId IdType="pubmed">12844284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindhurst MJ, Sapp JC, Teer JK, et al. . A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med
2011;365:611–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3170413</ArticleId>
            <ArticleId IdType="pubmed">21793738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I, et al. . CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS). Clin Genet
2017;91:14–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27426476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madsen RR, Vanhaesebroeck B, Semple RK. Cancer-associated PIK3CA mutations in overgrowth disorders. Trends Mol Med
2018;24:856–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6185869</ArticleId>
            <ArticleId IdType="pubmed">30197175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu F, Xie L, Ma JE, et al. . Lower expression of SLC27A1 enhances intramuscular fat deposition in chicken via down-regulated fatty acid oxidation mediated by CPT1A. Front Physiol
2017;8:449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5489693</ArticleId>
            <ArticleId IdType="pubmed">28706492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conti M, Peretti E, Cazzetta G, et al. . Frequency-modulated electromagnetic neural stimulation enhances cutaneous microvascular flow in patients with diabetic neuropathy. J Diabetes Complications
2009;23:46–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18403219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bocchi L, Evangelisti A, Barrella M, Scatizzi L, Bevilacqua M. Recovery of 0.1 Hz microvascular skin blood flow in dysautonomic diabetic (type 2) neuropathy by using Frequency Rhythmic Electrical Modulation System (FREMS). Med Eng Phys
2010;32:407–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20207576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bevilacqua M, Dominguez LJ, Barrella M, Barbagallo M. Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy. J Endocrinol Invest
2007;30:944–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18250616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barrella M, Toscano R, Goldoni M, Bevilacqua M. Frequency rhythmic electrical modulation system (FREMS) on H-reflex amplitudes in healthy subjects. Eura Medicophys
2007;43:37–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17159742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zecca M, Struhl G. A feed-forward circuit linking wingless, fat-dachsous signaling, and the warts-hippo pathway to Drosophila wing growth. PLoS Biol
2010;8:e1000386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2879410</ArticleId>
            <ArticleId IdType="pubmed">20532238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev
2013;27:355–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3589553</ArticleId>
            <ArticleId IdType="pubmed">23431053</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
